57 results on '"Cuomo R."'
Search Results
2. Nipple-areola complex reconstruction techniques: A literature review.
3. Myenteric neuronal loss in rats with experimental colitis: Role of tissue transglutaminase-induced apoptosis.
4. Effect of gluten-free diet and co-morbidity of irritable bowel syndrome-type symptoms on health-related quality of life in adult coeliac patients.
5. AF.54 EFFICACY OF USTEKINUMAB IN THE TREATMENT OF PATIENTS WITH CROHN'S DISEASE WITH FAILURE TO PREVIOUS CONVENTIONAL OR BIOLOGIC THERAPY: AN OBSERVATIONAL REAL-LIFE STUDY.
6. Food intake and gastrointestinal motility. A complex interplay
7. Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice
8. P.05.24 PROGRESSION RATE OF DIVERTICULOSIS AND DIVERTICULAR DISEASE DURING 1 YEAR OF FOLLOW-UP: RESULTS FROM ITALIAN NATIONWIDE REGISTRY (REMAD).
9. P.05.8 TRENDS IN HOSPITAL ADMISSION FOR ACUTE DIVERTICULITIS IN ITALY FROM 2008 TO 2015.
10. P.05.10 DEMOGRAPHIC AND CLINICAL FEATURES DISTINGUISH SUBGROUPS OF DIVERTICULAR DISEASE PATIENTS: RESULTS FROM ITALIAN NATIONWIDE REGISTRY (REMAD).
11. P.05.11 FEATURES OF ABDOMINAL PAIN MAY DISTINGUISH PATIENTS WITH PREVIOUS DIVERTICULITIS FROM PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE: RESULTS FROM THE ITALIAN REGISTRY OF DIVERTICULAR DISEASE (REMAD).
12. OC.03.5: Enteric Glia Regulates HIV-1 TAT-Induced Diarrhea and Triggers a Connexin 43-Mediated Activation of Central Nervous System Glia Leading to Cognitive Impairment in Rats.
13. OC.09.3 PALMITOYLETHANOLAMIDE (PEA) REDUCES COLITIS-INDUCED ANGIOGENESIS THROUGH AKT/MTOR PATHWAY INHIBITION.
14. P.08.9 CORRELATION BETWEEN HIGH RESOLUTION MANOMETRY PARAMETERS AND SYMPTOMS IN TREATED ACHALASIA PATIENTS.
15. P.03.13 PHENYLTHIOCARBAMIDE TASTING STATUS AFFECTS QUININE-MEDIATED REDUCTION OF FOOD INTAKE.
16. P.10.1 EFFECT OF ACID-SUPPRESSIVE THERAPY ON BASELINE IMPEDANCE IN NERD PATIENTS.
17. OC.02.1 MENTAL STRESS AND MEAL INDUCED SYMPATHETIC ACTIVITY IN POSTPRANDIAL DISTRESS SYNDROME PATIENTS: EFFECT OF DOMPERIDONE.
18. P.10.24 PRESENCE OF ATYPICAL AND PAINFUL SYMPTOMS CORRELATES WITH LOW BMI AND POOR QUALITY OF LIFE IN GERD PATIENTS.
19. P.10.25 EARLY CHANGES IN HRM-OESOPHAGEAL PARAMETERS IN PRE AND POST TREATMENT ACHALASIA PATIENTS.
20. OC.08.4 ENTEROGLIAL CELLS–BACTERIA INTERACTION MODULATES INTESTINAL EPITHELIAL CELLS DIFFERENTIATION.
21. P.18.6 ACETONIC EXTRACT FROM FEIJOA SELLOWIANA BERG. FRUITS INHIBITS PROLIFERATION AND MODULATES BRUSH BORDER MEMBRANE ENZYME ACTIVITIES IN HUMAN INTESTINAL EPITHELIAL CELLS.
22. P.20.15 GERD IS A PROTECTIVE RISK FACTOR FOR HYPERTENSION.
23. P.20.4 PPIS THERAPY NEEDING IN GERD PATIENTS WITH OVERLAPPING IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA.
24. P.20.2 REPRODUCIBILITY OF MULTICHANNEL ELECTROGASTROGRAPHY PARAMETERS IN DYSPEPTIC PATIENTS AND HEALTHY CONTROLS.
25. P.07.21 ADHERENCE TO MEDITERRANEAN DIET AND IBS SYMPTOMS IN ADOLESCENTS.
26. P.07.13 THE MEDITERRANEAN DIET IS A PROTECTIVE FACTOR AGAINST GASTROINTESTINAL SYMPTOMS IN YOUNG PEOPLE.
27. P.07.8 HUMAN ENTERIC GLIAL CELLS MODULATE INTESTINAL EPITHELIAL CELLS VIABILITY, PROLIFERATION AND DIFFERENTIATION: THE ROLE OF THE ENTEROGLIAL DERIVED S100B PROTEIN.
28. P.1.330: IRON ABSORPTION AFTER SINGLE ORAL DOSE OF FERROUS SULFATE OR FERRIC GLUCONATE IN PATIENTS WITH TOTAL GASTRECTOMY: PRELIMINARY DATA.
29. P.1.110: CLINICAL PATTERNS CAN DISTINGUISH DIVERTICULAR DISEASE FROM IRRITABLE BOWEL SYNDROME: A CASE-CASE MATCHING STUDY.
30. OC.05.2: PATHOGEN AND PROBIOTIC BACTERIA DIFFERENTIALLY STIMULATE NITRIC OXIDE PRODUCTION AND S100B PROTEIN EXPRESSION IN HUMAN ENTEROGLIAL CELLS.
31. P.1.215: RISK FACTORS ASSOCIATED WITH UNDESIRED BMI INCREASE IN GERD PATIENTS.
32. P.1.147: RAGE-DEPENDENT S100B PROTEIN MODULATION OF PERIPHERAL AND MUCOSAL IMMUNE CELLS' FUNCTIONS IN PATIENTS WITH ULCERATIVE COLITIS (UC).
33. P.1.225: PARTIALLY HYDROLYZED GUAR GUM (PHGG) IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME (IBS) WITH CONSTIPATION: EFFECTS OF GENDER, AGE AND BODY MASS INDEX (BMI).
34. P.55 EFFECT OF ENTEROGLIAL-DERIVED S100B PROTEIN ON PROLIFERATION AND RESPONSES IN HUMAN PERIPHERAL AND MUCOSAL IMMUNE CELLS.
35. P.31 FREQUENCY, SYMPTOMS EVOLUTION AND PATHOPHYSIOLOGICAL CORRELATES IN PROSPECTIVELY IDENTIFIED PATIENTS WITH POSTINFECTIOUS DYSPEPSIA.
36. P.36 ROLE OF NON-CALORIC CARBONATED BEVERAGE PRELOAD DURING A STANDARDIZED SOLID AND LIQUID MEAL ON COLECISTOKININ AND GHRELIN LEVELS IN HEALTHY SUBJECTS.
37. P.34 MENTAL STRESS INCREASES MEAL-INDUCED SYMPTOMS SEVERITY BY SYMPATHETIC HYPERACTIVITY AND ENHANCED ENDOCRINE RESPONSE IN PATIENTS WITH POSTPRANDIAL DISTRESS SYNDROME.
38. P.33 DOES THE PRELOAD OF A NON-CALORIC CARBONATED BEVERAGE, DURING A STANDARDIZED SOLID AND LIQUID MEAL, AFFECT GASTRIC VOLUME AND ENERGY INTAKE IN HEALTHY SUBJECTS?
39. OC.09.6 HUMAN DERIVED ENTEROGLIAL CELLS TOLL-LIKE RECEPTORS MRNA EXPRESSION AND MODULATION BY PATHOGENS AND PROBIOTIC BACTERIA.
40. OC.08.6 SIGNIFICANT ASSOCIATION OF LONGER FORMS OF CCTTT MICROSATELLITE REPEAT IN THE INDUCIBLE NITRIC OXIDE SYNTHASE PROMOTER WITH ACHALASIA.
41. PROTON PUMP INHIBITOR PRESCRIPTION FROM 2005 TO 2007 IN A PRIMARY CARE SETTING: IMPACT OF GENERIC DRUGS MARKET.
42. MEAL FORM INFLUENCES CCK RELEASE AND MAXIMUM SATIATION IN HEALTHY SUBJECTS.
43. ENTERIC GLIA STIMULATES INFLAMMATION-INDUCED RESPONSES IN HUMAN INTESTINE AND INTERACTS WITH IMMUNE CELLS VIA S100B PROTEIN.
44. EFFECT OF PROINFLAMMATORY STIMULI ON CELLULAR ACTIVATION AND NITRIC OXIDE PRODUCTION IN HUMAN PRIMARY ENTEROGLIAL CELLS.
45. PROTON PUMP INHIBITORS LONG-TERM THERAPY IMPAIRS ORO-CECAL TRANSIT TIME AND PREDISPOSES TO SMALL INTESTINAL BACTERIAL OVERGROWTH.
46. PA.185 EFFICACY OF LACTOBACILLUS PARACASEI F19 IN THE TREATMENT OF SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE (SUDD) OF THE COLON.
47. PA.180 EFFECT OF CARBONATED DRINKS ON UPPER DIGESTIVE TRACT SENSATIONS AND PHYSIOLOGY IN HEALTHY SUBJECTS.
48. PA.179 EFFECTS OF ORAL SUPPLEMENTATION WITH THE SYMBIOTIC (BIFIDOBACTERIUM LONGUM W11 + FOS ACTILIGHT) ON IBS WITH CONSTIPATION: A RANDOMIZED, DOSE FINDING TRIAL, VERSUS FIBERS.
49. PA.144 ENTERIC GLIAL PROTEIN S100B UP-REGULATION STIMULATES NITRIC OXIDE PRODUCTION IN ULCERATIVE COLITIS.
50. OC3.08.3 POPULATION-BASED STUDY ON SYMPTOMATIC CHARACTERIZATION OF UNCOMPLICATED COLON DIVERTICULAR DISEASE: A PRELIMINARY REPORT FROM DIVERTICULAR DISEASE ITALIAN GROUP.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.